FK 506 in cadaveric kidney transplantation from non-heart-beating donors.
Hattori
R
R
Department of Urology, Okazaki City Hospital, Aichi, Japan.
Ohshima
S
S
Ono
Y
Y
Fujita
T
T
Kinukawa
T
T
Matsuura
O
O
D000017:ABO Blood-Group System; D000328:Adult; D001787:Blood Group Incompatibility; D002102:Cadaver; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D006085:Graft Survival / Q000502:physiology*; D006323:Heart Arrest; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007668:Kidney; D016030:Kidney Transplantation / Q000276:immunology / Q000401:mortality / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D009392:Nephrectomy / Q000379:methods; D009926:Organ Preservation; D011183:Postoperative Complications; D012189:Retrospective Studies; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use*; D014019:Tissue Donors
D000017:ABO Blood-Group System; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus